News
The health sector is abuzz with significant news: from FDA approvals of novel drugs and mergers like Merck's acquisition of ...
Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...
Market Growth: The sulfuric acid market is projected to grow from USD 15,800.2 million in 2024 to USD 24,021.7 million by ...
The Hormone Replacement Therapy Market is estimated to grow at a CAGR of 6.48% during the forecast period from 2024 to 2030.
Rheumatologists and dermatologists highlight Saphnelo, Sotyktu, and litifilimab as leading candidates to address unmet needs in CLE patients, particu ...
Merck & Co. Inc. managers escaped allegations that they hurt the pharmaceutical giant by misleading investors over traction ...
Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...
Borussia Dortmund have agreed a new deal with Under-19 head coach Mike Tullberg, the club have announced. In the process of ...
A tricky buy-out clause coupled with the start date of the FIFA Club World Cup is complicating BVB’s intentions with Carney ...
Borussia Dortmund have agreed a new deal with Under-19 head coach Mike Tullberg, the club have announced. In the process of ...
Merck, the New Jersey-based drug giant, is spending $1 billion on a new Delaware factory to bring production of its best-selling cancer drug Keytruda to the U.S. and speed future drugs to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results